Live Oak Health Sciences Fund

Investment Goal

Live Oak Health Sciences Fund seeks long-term growth by investing in common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences.

Investment Approach

Live Oak invests in "health science" companies, which may include pharmaceutical firms, designers and manufacturers of medical equipment and supplies, operators of hospitals and other health care services, and biotechnological researchers and developers. Live Oak focuses on the market leaders who are well positioned to take advantage of technological advances, innovative changes and demographic trends affecting the health sciences and biotechnology industries. Live Oak generally invests in large- and-mid capitalization companies, but can invest in companies of any size.

The manager identifies what he believes to be the most attractive areas within health science and then narrows his search to individual stocks, paying particular attention to companies who are well positioned to take advantage of technological advances, innovative changes and demographic trends affecting the health science industry. The manager’s stock selection process is based on a quantitative and qualitative analysis of individual companies’ fundamentals such as valuation, earnings growth potential, competitive advantages and the quality of corporate management. The fund generally invests in large- and medium-capitalization companies, but can invest in companies of any size. The manager invests with a long-term focus and seeks to keep the Fund’s portfolio turnover to a minimum relative to its peers.


Portfolio Manager

Mark W. Oelschlager, CFA >>


Quarterly Factsheet

Download PDF

Portfolio Holdings

As of June 30, 2017
Total Holdings 33
Total Fund Assets $70 million
Aetna, Inc.AET
Amgen, Inc.AMGN
Anthem, Inc.ANTM
Becton Dickinson and Co.BDX
Biogen, Inc.BIIB
Bioverativ, Inc.BIVV
Cardinal Health, Inc.CAH
Charles River Laboratories International, Inc.CRL
Cigna Corp.CI
CR Bard, Inc.BCR
CVS Health Corp.CVS
DaVita HealthCare Partners, Inc.DVA
Eli Lilly & Co.LLY
Endo International PLCENDP
Express Scripts Holding Co.ESRX
GlaxoSmithKline PLCGSK
Halyard Health, Inc.HYH
Johnson & JohnsonJNJ
Keysight Technologies, Inc.KEYS
McKesson Corp.MCK
Medtronic PLCMDT
Merck & Co., Inc.MRK
Owens & Minor, Inc.OMI
Quest Diagnostics, Inc.DGX
Sanofi - ADRSNY
Stryker Corp.SYK
Teva Pharmaceutical Industries, Ltd.TEVA
UnitedHealth Group, Inc.UNH
Us DollarsUSD
Waters Corp.WAT

The aggregate percentage
of the top 10 holdings is: 44.89%

Fund Data

Ticker Symbol LOGSX
Minimum Investment $2,000
Min. Subsequent Investment $25
Load None
Cusip 671081503
Net Expense Ratio 1.15%
Gross Expense Ratio 1.15%

Daily Performance

As of July 27, 2017
Share Price $20.62   
Change $‑0.16   
As of July 27, 2017
Year-to-Date Performance 13.11%

Monthly Performance

As of May 31, 2017
1 Year 7.49%
3 Year 9.62%
5 Year 16.99%
10 Year 10.76%
Since Inception 7.93%
Inception Date June 29, 2001

Quarterly Performance

As of March 31, 2017
1 Year 10.18%
3 Year 9.07%
5 Year 14.82%
10 Year 11.08%
Since Inception 7.82%
Inception Date June 29, 2001

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. For performance data current to the most recent month end, please click on the individual fund name in the Fund Center on the homepage or call 1-888-462-5386. Holdings are subject to change.

All returns for periods greater than one year are annualized. If the Fund is less than 1 year old, cumulative since inception returns are shown. If the Fund is less than 10 years old, annualized return since inception is shown. All year-to-date returns are cumulative.